✦ LIBER ✦

Safety of low-density lipoprotein cholesterol reduction with atorvastatin versus simvastatin in a coronary heart disease population (the TARGET TANGIBLE Trial)

✍ Scribed by Winfried März; Helmut Wollschläger; Gernot Klein; Albrecht Neiß; Martin Wehling

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduction in coronary heart disease with

✍ Hisato Takagi; Takuya Umemoto 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Safety and Efficacy of Atorvastatin-Indu

✍ John C. LaRosa; Scott M. Grundy; John J.P. Kastelein; John B. Kostis; Heiner Gre 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 197 KB

Reduction of low-density lipoprotein cho

✍ Prakash Deedwania; Philip Barter; Rafael Carmena; Jean-Charles Fruchart; Scott M 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 137 KB

Safety and tolerability of simvastatin p

✍ Xue-Qiao Zhao; Josh S Morse; Alice A Dowdy; Nancy Heise; Debbie DeAngelis; Jiri 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Relation of Clinical Benefit of Raising

✍ Ilan Goldenberg; Michal Benderly; Roy Sidi; Valentina Boyko; Alexander Tenenbaum 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 385 KB

Efficacy of atorvastatin in achieving Na

✍ Ruth McPherson; Carmella Angus; Peter Murray; Jacques Genest Jr 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 128 KB